Kymera Therapeutics (KYMR) Cash from Investing Activities (QoQ) (2020 - 2026)
Kymera Therapeutics (KYMR) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.78% |
| Dec 31, 2025 | -67.62% |
| Sep 30, 2025 | -492.03% |
| Jun 30, 2025 | 23.46% |
| Mar 31, 2025 | -29.10% |
| Dec 31, 2024 | 143.49% |
| Sep 30, 2024 | -1,108.06% |
| Jun 30, 2024 | 104.73% |
| Mar 31, 2024 | -1,844.44% |
| Dec 31, 2023 | -68.68% |
| Sep 30, 2023 | 68.84% |
| Jun 30, 2023 | 45.78% |
| Mar 31, 2023 | 149.50% |
| Dec 31, 2022 | -32.51% |
| Sep 30, 2022 | -145.82% |
| Jun 30, 2022 | 216.29% |
| Mar 31, 2022 | 138.02% |
| Dec 31, 2021 | 50.30% |
| Sep 30, 2021 | -325.39% |
| Jun 30, 2021 | 37.00% |